New York, NY -- (SBWIRE) -- 12/11/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Coronado Biosciences Inc (NASDAQ:CNDO), Himax Technologies, Inc. (ADR) (NASDAQ:HIMX), BioNeutral Group Inc (OTCMKTS:BONU), Oracle Corporation (NYSE:ORCL)
Coronado Biosciences Inc (NASDAQ:CNDO) showed a volume of 3.73 million shares by the end of last trade whereas the average volume of the stock remained 1.33 million shares. The stock opened the session at $2.00 but then moved to $1.80. At that price, the stock showed a negative performance of -7.69%. Coronado Biosciences, Inc. is a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer. The Company’s two principal pharmaceutical product candidates in clinical development include Trichuris suis ova or CNDO-201 (TSO) a biologic comprising of the microscopic eggs of the porcine whipworm, for the treatment of autoimmune diseases, such as Crohn’s disease (Crohn’s),
Will CNDO Get Buyers Even After The Recent Rally? Find Out Here
Himax Technologies, Inc. (ADR) (NASDAQ:HIMX) opened the session at $10.35and closed the session at $11.02. The stock showed a positive performance of 5.60% in previous trading session. Traded with volume of 6.26 million shares in the prior session and the average volume of the stock remained 6.73 million shares. Himax Technologies, Inc. operates as an IC design house with LCD manufacturing capability. The Company focuses on display IC products for display device and offers LCD technical consulting to customers to provide them with value-added technical support and integrated solutions.
For How Long HIMX will fight for Profitability? Read This Trend Analysis report
BioNeutral Group Inc (OTCMKTS:BONU) opened the session at $0.0001 and closed the session at $0.0021. The stock showed a positive performance of 61.54% in previous trading session. Traded with volume of 67.31 million shares in the prior session and the average volume of the stock remained 20.70 million shares. The beta of the stock remained -180.45. BioNeutral Group, Inc. is a life science specialty technology company. The Company is a specialty chemical company that focuses on developing and commercializing a combinational chemistry based technology, which can neutralize harmful environmental contaminants, toxins and dangerous micro-organisms, including bacteria, viruses and spores. The Company’s business operations are conducted through BioNeutral Laboratories Corporation USA (BioLabs).
Why Should Investors Buy BONU After The Recent Gain? Just Go Here and Find Out
Oracle Corporation (NYSE:ORCL) the stock decreased -2.25% and finished the session at $34.80. Traded with volume of 25.49 million shares in the prior session and the average volume of the stock remained 16.62 million shares. The beta of the stock remained 1.16. Oracle Corporation is a provider of enterprise software and computer hardware products and services. The Company's software, hardware systems, and services businesses develops, manufactures, markets, hosts and supports database and middleware software, applications software, and hardware systems, with the latter consisting primarily of computer server and storage products. It is organized into three businesses: software, hardware systems and services.
Will ORCL Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)